Skip to content

Author

Yongkui Yu

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Upfront surgery versus neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma in elderly patients: a multicenter cohort study

The optimal treatment strategy for elderly patients (aged ≥65 years) with operable locally advanced esophageal squamous cell carcinoma (ESCC) remains controversial. This study aimed to compare the survival outcomes of upfront surgery (US), neoadjuvant chemoimmunotherapy (nCIT), and neoadjuvant chemoradiotherapy (nC...

Z. Hou, Yi-Xiang Zhu, M. Lan et al. · 0 citations
Review Open access Aug 2026

A review of soluble mediator and cytokine networks linking combination immunotherapy, tumor microenvironment remodeling and skeletal muscle dysfunction

An integrated mechanistic and translational framework is established to advance holistic oncologic care that reconciles robust anti-tumor immunity with sustained skeletal muscle integrity that reconciles robust anti-tumor immunity with sustained skeletal muscle integrity.

Jia-Xuan Wu, Ying Lu, Jiaqi Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.